Recent research presented at the European Respiratory Society Congress in Barcelona reveals that individuals diagnosed with lung cancer possess higher concentrations of microplastics in their lungs compared to non-cancer patients. Investigators analyzed lung-wash and tissue samples, identifying polypropylene and polyethylene particles embedded within human respiratory tracts.
As environmental plastic pollution proliferates globally, clinical researchers are examining the intersection of airborne toxins and the formation of cancer. While environmental exposure to microscopic synthetic debris is nearly ubiquitous, this recent data from European researchers sheds light on how these materials accumulate inside human respiratory systems. Understanding the particulate burden in diseased versus healthy tissue marks a step in evaluating environmental impacts on pulmonary health.
In Plain English: The Clinical Takeaway
- The Discovery: Investigators found that patients with lung cancer had a higher overall burden of microplastics in their lung samples than patients without cancer.
- Common Polymers: Polypropylene and polyethylene, materials found in consumer packaging and textiles, were identified as the most frequent contaminants.
- Distribution Patterns: Particles do not distribute evenly across the lung; lung-wash samples and solid tissue samples showed varying concentrations within the same individuals.
Clinical Findings and Sample Analysis
The research, presented by Dr. Ilias Dimeas from the University College Dublin School of Medicine and the University of Thessaly, included 100 participants undergoing diagnostic bronchoscopies at the University Hospital of Larissa in Greece. A bronchoscopy is a medical procedure where a thin, flexible tube equipped with a camera is guided into the airways to examine tissue and collect samples. During this procedure, clinicians gathered lung-wash samples—utilizing a saline solution flush to harvest cells from the airspaces—alongside targeted tissue biopsies from a subset of participants.
Laboratory analysis of these specimens revealed a total of 232 microplastic particles. Overall, 70% of the patient cohort exhibited detectable microplastics in at least one sample type. When stratifying the cohort, individuals diagnosed with lung cancer demonstrated a higher frequency of detection and total burden in their lung-wash samples (66% versus 46%) compared to the group of non-cancer patients.
Comparison between the liquid lung-wash samples and solid tissue samples yielded a physiological observation. Patients exhibiting higher microplastic counts in their washes often displayed lower counts in their corresponding tissue samples, and vice versa. According to the research team, this relationship indicates that particulate retention varies depending on whether the particles reside in the airspaces or are embedded within the lung itself.
| Clinical Parameter | Lung Cancer Cohort (N=50) | Control Cohort (N=50) |
|---|---|---|
| Overall Microplastic Detection Rate | Higher prevalence | Lower prevalence |
| Lung-Wash Detection Rate | 66% positive | 46% positive |
| Primary Polymer Types Identified | Polypropylene, Polyethylene | Polypropylene, Polyethylene |
| Primary Sampling Methods | Bronchoscopy lavage & tissue biopsy | Bronchoscopy lavage & tissue biopsy |
Pathophysiological Implications and Environmental Context
Inhalation represents a vector for human exposure to microplastics. As airborne synthetic fibers and fragments enter the respiratory tract, they settle within the lungs.
Dr. Dimeas noted the core clinical question raised by the data:
“Microplastics have become an unavoidable part of our environment, but we still know remarkably little about what happens once they enter the human body. We don’t yet know what the background levels of microplastics in the lungs are, how much they vary from person to person, or whether they contribute to disease. If we are breathing these particles in every day, we need to understand where they end up and whether they could be linked to disease.” University College Dublin School
Researchers are investigating whether these foreign polymers contribute to inflammation or other biological processes that may contribute to diseases like cancer, or if diseased lungs simply retain particles differently than healthy lungs.
Conclusion
The identification of polypropylene and polyethylene particles within human lung tissue underscores the nature of environmental pollution. While this research establishes a correlation between elevated microplastic burden and lung cancer diagnoses, further study is required to define causal pathways.
References
- European Respiratory Society (ERS). Patients diagnosed with lung cancer found to have more microplastic in lungs. September 2026.
